Send us a link

Subscribe to our newsletter

Political Party, not Scientific Background, Shapes Americans’ View of Climate Change

Political Party, not Scientific Background, Shapes Americans’ View of Climate Change

A poll revealed today that Americans are still majorly divided on the causes and cures of climate change, The New York Times reports.

The boldness of philanthropists

The boldness of philanthropists

Last week, Priscilla Chan and Mark Zuckerberg announced their new philanthropic initiative with the goal of “curing, preventing, and managing all diseases by the end of the century.” This may raise some eyebrows, but this effort—part of the $45 billion Chan Zuckerberg Initiative—joins forces with other philanthropists to push the envelope and support audacious ideas, with long-term commitments, to solve some of our greatest challenges.

The FDA's drug reviewers keep leaving to work for big pharma, and it's a big problem

The FDA's drug reviewers keep leaving to work for big pharma, and it's a big problem

This revolving door problem isn’t unique to the FDA; it’s an issue for all government-regulated industries.

Tougher rules for clinical-trial transparency

Tougher rules for clinical-trial transparency

Investigators are now required to disclose all clinical trials, whether successful or not.

Clinical trial rules aim to improve public reporting of results

Clinical trial rules aim to improve public reporting of results

Researchers will have to publicly report the results of many more clinical trials under new government rules announced Friday.

Report urges to make room for science in the White House

Report urges to make room for science in the White House

The 20-page report has an explicit message: The White House Office of Science and Technology Policy (OSTP) and the position of the president’s science adviser should be retained.

Congress faces a lengthy science to-do list

Congress faces a lengthy science to-do list

Congress returns in early September from a 7-week summer break with a lengthy list of unfinished business, some of great interest to the U.S. research community—and just a few weeks to tackle it.

Research watchdog's new leader faces staff revolt

Research watchdog's new leader faces staff revolt

The new director of the federal office that guards against misconduct in U.S.-funded biomedical research is aiming to shake things up—but is also encountering rough waters. Kathryn Partin, who took the helm of the Office of Research Integrity (ORI) in December 2015, has launched a top-to-bottom review of the office, which has been criticized for moving too slowly and meting out sanctions that lack teeth.

The Untold History of Women in Science and Technology

The Untold History of Women in Science and Technology

Listen to women from across the Administration tell the stories of their personal heroes across the fields of science, technology, engineering, and math (STEM).

Donald Trump's Lack of Respect for Science Is Alarming

Donald Trump's Lack of Respect for Science Is Alarming

The U.S. presidential election shows how far the political conversation has degenerated from the nation's founding principles of truth and evidence.

NSF tries two-step review, drawing praise—and darts

NSF tries two-step review, drawing praise—and darts

Thousands of conservation and environmental biologists must now survive two rounds of peer review before getting funding from the National Science Foundation (NSF). NSF says that the two-stage review process, which it launched 4 years ago as a pilot project in two divisions within its biology directorate, has resulted in a more manageable workload and fuller consideration of the highest-quality proposals.

NIH moves to lift moratorium on animal-human chimera research

NIH moves to lift moratorium on animal-human chimera research

Controversial studies of animals containing human stem cells could be funded if they pass agency ethics review

Trump vs Clinton: worlds apart on science

Trump vs Clinton: worlds apart on science

Presidential candidates begin to make clear their stark differences on climate change, energy production and stem-cell research.

In First for Sitting President, Obama Publishes a Scholarly Article

In First for Sitting President, Obama Publishes a Scholarly Article

Obama Just Did Something No President Has Ever Done: Call him scholar-in-chief

Obama’s top scientist talks shrinking budgets, Donald Trump, and his biggest regret

Obama’s top scientist talks shrinking budgets, Donald Trump, and his biggest regret

John Holdren tells Nature about the highs and lows of nearly eight years in the White House.

100 Examples of President Obama’s Leadership in Science, Technology, and Innovation

100 Examples of President Obama’s Leadership in Science, Technology, and Innovation

“We’ll restore science to its rightful place." President Obama’s Inaugural Address, 2009